Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 2
2019 2
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours.
Genestie C, Blanc-Durand F, Auguste A, Pautier P, Dunant A, Scoazec JY, Gouy S, Morice P, Bentivegna E, Maulard A, LeFormal A, Devouassoux-Shisheboran M, Leary A. Genestie C, et al. Among authors: blanc durand f. Br J Cancer. 2020 Feb;122(4):564-568. doi: 10.1038/s41416-019-0687-z. Epub 2019 Dec 17. Br J Cancer. 2020. PMID: 31844183
[Hot topics about early clinical trials at ASCO congress 2018: News pathways, new targets, new associations].
Auvray M, Baylot C, Blanc-Durand F, Borcoman E, Pons-Tostivint E, Vignot S. Auvray M, et al. Among authors: blanc durand f. Bull Cancer. 2018 Nov;105(11):1084-1093. doi: 10.1016/j.bulcan.2018.08.010. Epub 2018 Oct 16. Bull Cancer. 2018. PMID: 30340752 Review. French.
[A GERCOR-AERIO national survey of oncology residents in France: Current setting and expectations regarding post-internship and research].
Hilmi M, Rousseau B, Cohen R, Vienot A, Vernerey D, Bartholin L, Blanc-Durand F, Louvet C, Turpin A, Neuzillet C. Hilmi M, et al. Among authors: blanc durand f. Bull Cancer. 2019 May;106(5):407-420. doi: 10.1016/j.bulcan.2019.02.009. Epub 2019 Apr 12. Bull Cancer. 2019. PMID: 30987751 French.
Safety and efficacy of 2-weekly cabazitaxel in metastatic castration-resistant prostate cancer.
Clément-Zhao A, Auvray M, Aboudagga H, Blanc-Durand F, Angelergues A, Vano YA, Mercier F, El Awadly N, Verret B, Thibault C, Oudard S. Clément-Zhao A, et al. Among authors: blanc durand f. BJU Int. 2018 Feb;121(2):203-208. doi: 10.1111/bju.13855. Epub 2017 Apr 27. BJU Int. 2018. PMID: 28370882 Free article.
Tepotinib Efficacy in a Patient with Non-Small Cell Lung Cancer with Brain Metastasis Harboring an HLA-DRB1-MET Gene Fusion.
Blanc-Durand F, Alameddine R, Iafrate AJ, Tran-Thanh D, Lo YC, Blais N, Routy B, Tehfé M, Leduc C, Romeo P, Stephenson P, Florescu M. Blanc-Durand F, et al. Oncologist. 2020 Jul 27. doi: 10.1634/theoncologist.2020-0502. Online ahead of print. Oncologist. 2020. PMID: 32716573 Free article.
Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT).
Blanc-Durand F, Lefeuvre-Plesse C, Ray-Coquard I, Chaltiel D, Floquet A, Meriaux É, Berton D, Bello-Roufai D, Guillemet C, Dupre PF, Faller É, Alexandre J, Hardy-Bressard AC, Collard O, Fabbro M, Provansal M, Kalbacher E, Genestie C, Pautier P. Blanc-Durand F, et al. Gynecol Oncol. 2020 Jul 25:S0090-8258(20)33654-4. doi: 10.1016/j.ygyno.2020.07.019. Online ahead of print. Gynecol Oncol. 2020. PMID: 32723678
Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer.
Leary A, Genestie C, Blanc-Durand F, Gouy S, Dunant A, Maulard A, Drusch F, Cheaib B, Michels J, Bentivegna E, LeFormal A, Mesnage S, Morice P, Pautier P, Khairallah AS. Leary A, et al. Among authors: blanc durand f. Cancer Immunol Immunother. 2020 Aug 27. doi: 10.1007/s00262-020-02670-0. Online ahead of print. Cancer Immunol Immunother. 2020. PMID: 32852603
Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis.
Auguste A, Blanc-Durand F, Deloger M, Le Formal A, Bareja R, Wilkes DC, Richon C, Brunn B, Caron O, Devouassoux-Shisheboran M, Gouy S, Morice P, Bentivegna E, Sboner A, Elemento O, Rubin MA, Pautier P, Genestie C, Cyrta J, Leary A. Auguste A, et al. Among authors: blanc durand f. Cells. 2020 Jun 19;9(6):1496. doi: 10.3390/cells9061496. Cells. 2020. PMID: 32575483 Free PMC article.